Quantcast
Channel: BioTuesdays » drug delivery
Browsing all 3 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

D. Medical completes sale of NextGen Biomed

D. Medical Industries (NASDAQ, TASE:DMED) has closed the sale of its holdings in its publicly held subsidiary, NextGen Biomed, for $1.6 million. D. Medical is a medical device company engaged through...

View Article



Image may be NSFW.
Clik here to view.

D. Medical gets first payment under worldwide OEM pact

D. Medical Industries (NASDAQ, TASE:DMED) has received the first payment under an original equipment manufacturer agreement with Twobiens Ltd., a leading South Korea-based supplier of diabetes...

View Article

Image may be NSFW.
Clik here to view.

DURECT awaiting Pfizer meeting with FDA on Remoxy

DURECT (NASDAQ:DRRX) has a lot riding on a meeting in late March between its marketing partner, Pfizer, and the FDA to discuss resubmitting a new drug application for its lead pain drug, Remoxy, as a...

View Article
Browsing all 3 articles
Browse latest View live




Latest Images